SECURITY AGREEMENTSecurity Agreement • April 21st, 2020 • Nemaura Medical Inc. • Surgical & medical instruments & apparatus • Utah
THIS SECURITY AGREEMENT (this “Agreement”), dated as of April 15, 2020, is executed by Nemaura Medical Inc., a Nevada corporation (“Nemaura”), Dermal Diagnostics Limited, an England and Wales corporation (“Dermal Diagnostics”), and Trial Clinic Limited, an England and Wales corporation (“Trial Clinic,” and together with Nemaura and Dermal Diagnostics, “Debtor”), in favor of Chicago Venture Partners, L.P., a Utah limited partnership (“Secured Party”).
ContractNote • April 21st, 2020 • Nemaura Medical Inc. • Surgical & medical instruments & apparatus • Utah
THIS NOTE (AS DEFINED BELOW) MAY NOT BE SOLD, TRANSFERRED, ASSIGNED, PLEDGED, HYPOTHECATED OR OTHERWISE ALIENATED OR ENCUMBERED WITHOUT THE PRIOR WRITTEN CONSENT OF INVESTOR (AS DEFINED BELOW). THIS NOTE IS SUBJECT TO A RIGHT OF OFFSET IN FAVOR OF INVESTOR UPON THE OCCURRENCE OF CERTAIN EVENTS AS SET FORTH IN MORE DETAIL IN SECTION 4 BELOW.
NOTE PURCHASE AGREEMENTSecurity Agreement • April 21st, 2020 • Nemaura Medical Inc. • Surgical & medical instruments & apparatus • Utah
THIS NOTE PURCHASE AGREEMENT (this “Agreement”), dated as of April 15, 2020, is entered into by and among NEMAURA EDICAL INC., a Nevada corporation (“Company”), DERMAL DIAGNOSTICS LIMITED, an England and Wales corporation (“Dermal Diagnostics”), TRIAL CLINIC LIMITED, an England and Wales corporation (“Trial Clinic,” and together with Dermal Diagnostics and Company, “Borrower”), and CHICAGO VENTURE PARTNERS, L.P., a Utah limited partnership, its successors and/or assigns (“Investor”).
